12:00 AM
 | 
Apr 26, 2010
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Precedex dexmedetomidine: Phase III data

Top-line data from the double-blind, international Phase III PRODEX trial in 500 medical and surgical ICU patients requiring light to moderate sedation for mechanical ventilation showed that Precedex met the co-primary endpoint of providing...

Read the full 157 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >